QMENTA Imaging

QMENTA AI Reader can ensure the success of the trial by helping experts to choose patients at the right stage of the disease and qualitatively demonstrate the efficacy of the treatment during the course of the trial using QMENTA's state-of-the-art neurological AI algorithms.

It aims to save substantial time and resources for the sponsor and the CRO by automating the manual work of the experts, optimizing the use of resources and minimizing the burden on the site. QMENTA AI Reader offers tools for diagnosis, prognosis, monitoring, and decision support for experts and physicians, freeing up their time by automating manual tasks and extracting valuable information from raw images to facilitate decision making.

QMENTA's neuro IA tools provide a unique view of brain anatomy by accentuating tissue change or damage or hyperintensities in colour and 3D, and by creating maps of the brain network to see changes in connections due to disease or injury. These state-of-the-art algorithms, driven by deep, machine learning, help clinicians accurately assess patients and their disease status based on objective criteria.

His vision is to live in a world where brain diseases can be cured or prevented, a world where brain diseases are a thing of the past.

Its mission is to organize and quantify brain imaging information through advanced imaging tools and deliver it to experts in a transparent manner.

Its goal is to change the way patients are diagnosed and monitored, and to measure disease progression and drug efficacy; to date, this represents one of the greatest health challenges for aging societies in the world.

The turnover is expected to grow to 100M euros per year in 5 years.

Strong investment in R&D.